{"id":29973,"date":"2022-02-17T23:39:25","date_gmt":"2022-02-18T04:39:25","guid":{"rendered":"http:\/\/www.veeva.com\/kr\/?post_type=resources&#038;p=29973"},"modified":"2026-03-26T05:27:12","modified_gmt":"2026-03-26T09:27:12","slug":"keryx-biopharmaceuticals-turns-to-veeva-commercial-cloud-to-support-first-fda-approved-product-launch","status":"publish","type":"resources","link":"https:\/\/www.veeva.com\/kr\/resources\/keryx-biopharmaceuticals-turns-to-veeva-commercial-cloud-to-support-first-fda-approved-product-launch\/","title":{"rendered":"Keryx Biopharmaceuticals Turns to Veeva Commercial Cloud to Support First FDA-Approved Product Launch"},"content":{"rendered":"<p><strong>PLEASANTON, CA \u2013 Jan. 8, 2015<\/strong> <strong>\u2013<\/strong> In 2014, Keryx Biopharmaceuticals needed to quickly build a commercial foundation for product sales and marketing to support its first FDA-approved product, Auryxia&#x2122; (ferric citrate). Keryx required a best-of-breed solution that would enable business agility and continuous improvement, plus easily accommodate change and rapid growth. Keryx found it in Veeva Commercial Cloud \u2013 a single solution that brings together customer data, multichannel interactions, and compliant content for a fully orchestrated customer experience. At launch, Keryx was ready with Veeva Commercial Cloud, including Veeva CRM, Veeva CRM Approved Email, and closed loop marketing (CLM); Veeva Vault PromoMats for promotional materials management; and Veeva Network customer master.<\/p>\n<p>\u201cWe have adopted a holistic, customer-centric strategy by implementing a cloud platform that enables information sharing between sales and marketing. With Veeva as our foundation, we can develop relevant multichannel programs that allow us to engage with customers on their terms,\u201d said Keryx Vice President of Marketing and Operations Abraham Ceesay.<\/p>\n<p>Keryx started product commercialization planning with a blank slate and a simple goal: to best enable its field teams and provide a differentiated customer experience. Keryx Director of Commercial Operations Matt Nestor knew that establishing its commercial operations in the cloud would meet Keryx\u2019s immediate needs cost effectively while supporting its customer interaction goals.<\/p>\n<p>\u201cFreed from the burden of legacy systems, we were able to quickly set up our commercial infrastructure the right way, the first time, with input and ownership from sales and marketing,\u201d said Nestor. \u201cVeeva Commercial Cloud gives us a complete solution for data, content management, and multichannel CRM \u2013 key to more agile, efficient, and effective commercialization.\u201d<\/p>\n<p>Veeva CRM, Veeva Commercial Cloud\u2019s flagship application, provides Keryx the advantage of a proven, life sciences-specific solution, making it quick to implement and easy to use. It brings all customer interactions across channels together with Veeva CRM Approved Email for compliant email communications and Veeva CLM for field detailing, providing commercial teams with deeper insights into the business. All channels are supported by Vault PromoMats, the company\u2019s solution for promotional materials management, enabling immediate distribution of approved, compliant content to the field force.<\/p>\n<p>\u201cWith Veeva CRM, our sales teams can hold an ongoing conversation with the customer in person and continue the interaction through email, in a compliant manner, while meeting customers\u2019 needs for information. Approved Email with content direct from Vault PromoMats allows reps to follow up on conversations or start new ones using the latest materials without compliance risk. And, Veeva CLM feeds insights from the field directly to marketing, and vice versa, for harmonized, more successful selling,\u201d said Nestor. \u201cHaving a complete view of the customer\u2019s experience with the rep \u2013 including pre-call, in-call, and post-call activities \u2013 in a single solution enables us to create a premier sales force that\u2019s laser-focused on customer needs.\u201d<\/p>\n<p>Keryx brand teams are leveraging Veeva Commercial Cloud in other ways, too, such as fast-tracking approvals of its new launch campaign with Vault PromoMats. Keryx can now speed the creation, MLR review, distribution, and withdrawal of marketing materials.<\/p>\n<p>Keryx also benefits from complete, always up-to-date customer data with Veeva Network. The company receives the latest healthcare professional (HCP), healthcare organization (HCO), and affiliations data directly from Veeva Network for accurate customer profiles generated from authoritative industry sources worldwide. The data also improves over time as users in the field continuously contribute updates through Veeva CRM that are independently verified by data stewards.<\/p>\n<p>Keryx chose Veeva Commercial Cloud not only for the best-in-class master data management, content management, and CRM capabilities, but also for the enhanced value it provides as a whole. Eliminating the barriers between sales and marketing, Veeva Commercial Cloud delivers a full view of the customer and enables Keryx to synchronize communications across channels to maximize impact and optimize resources. Keryx can change and scale the solution as needed so commercial teams remain agile and are always working on the latest innovations. \u201cWe are making it easy for our customers to innovate by creating the very best applications for their key commercial functions, all seamlessly connected in the cloud,\u201d explained Paul Shawah, vice president of product marketing at Veeva.<\/p>\n<p><strong>Additional Information:<\/strong><\/p>\n<p style=\"padding-left: 30px;\">\u2022 For more information on Veeva Commercial Cloud, please visit: <a href=\"http:\/\/veeva.com\/commercial-solutions\">www.veeva.com\/commercial-solutions<\/a><\/p>\n<p style=\"padding-left: 30px;\">\u2022 Stay updated on the latest Veeva news on LinkedIn: <a href=\"http:\/\/www.linkedin.com\/company\/veeva-systems\">www.linkedin.com\/company\/veeva-systems<\/a><\/p>\n<p style=\"padding-left: 30px;\">\u2022 Follow @veevasystems on Twitter: <a href=\"https:\/\/twitter.com\/veevasystems\">www.twitter.com\/veevasystems<\/a><\/p>\n<p style=\"padding-left: 30px;\">\u2022 Like Veeva on Facebook: <a href=\"https:\/\/www.facebook.com\/VeevaSystems\">www.facebook.com\/veevasystems<\/a><\/p>\n<p><strong>About Veeva Systems<br \/>\n<\/strong>Veeva Systems Inc. is a leader in cloud-based software for the global life sciences industry. Committed to innovation, product excellence, and customer success, Veeva has more than 200 customers, ranging from the world\u2019s largest pharmaceutical companies to emerging biotechs. Veeva is headquartered in the San Francisco Bay Area, with offices in Europe, Asia, and Latin America. For more information, visit www.veeva.com.<\/p>\n<p><strong>Forward-looking Statements<br \/>\n<\/strong>This release contains forward-looking statements, including statements regarding benefits from the use of Veeva\u2019s solutions, demand for Veeva\u2019s solutions, and general business conditions. Any forward-looking statements contained in this press release are based upon Veeva\u2019s historical performance and its current plans, estimates and expectations and are not a representation that such plans, estimates, or expectations will be achieved. These forward-looking statements represent Veeva\u2019s expectations as of the date of this press announcement. Subsequent events may cause these expectations to change, and Veeva disclaims any obligation to update the forward-looking statements in the future. These forward-looking statements are subject to known and unknown risks and uncertainties that may cause actual results to differ materially. Additional risks and uncertainties that could affect Veeva\u2019s financial results are included under the captions \u201cRisk Factors\u201d and \u201cManagement\u2019s Discussion and Analysis of Financial Condition and Results of Operations,\u201d in the company\u2019s filing on Form 10-Q for the period ended July 31, 2014, which is available on the company\u2019s website at www.veeva.com under the Investors section and on the SEC\u2019s website at www.sec.gov. Further information on potential risks that could affect actual results will be included in other filings Veeva makes with the SEC from time to time.<\/p>\n<p><strong>###<\/strong><\/p>\n<p><strong>Contact:<br \/>\n<\/strong>Lisa Barbadora<br \/>\nPublic Relations<br \/>\nVeeva Systems Inc.<br \/>\n610-420-3413<br \/>\n<a href=\"mailto:pr@veeva.com\">pr@veeva.com<\/a><\/p>\n<p>&nbsp;<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Keryx turns to Veeva Commercial Cloud to support first FDA-approved product launch.<\/p>\n","protected":false},"featured_media":30357,"parent":0,"template":"","class_list":["post-29973","resources","type-resources","status-publish","has-post-thumbnail","hentry","resource-area-commercial","resource-type-news-press-release","resource-type-press-release","resource-product-commercial-cloud-complete-commercial","resource-product-commercial-content","resource-product-medical-crm"],"aioseo_notices":[],"aioseo_head":"\n\t\t<!-- All in One SEO Pro 5.0.1 - aioseo.com -->\n\t<meta name=\"description\" content=\"Keryx turns to Veeva Commercial Cloud to support first FDA-approved product launch.\" \/>\n\t<meta name=\"robots\" content=\"max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n\t<link rel=\"canonical\" href=\"https:\/\/www.veeva.com\/kr\/resources\/keryx-biopharmaceuticals-turns-to-veeva-commercial-cloud-to-support-first-fda-approved-product-launch\/\" \/>\n\t<meta name=\"generator\" content=\"All in One SEO Pro (AIOSEO) 5.0.1\" \/>\n\t\t<meta property=\"og:locale\" content=\"ko_KR\" \/>\n\t\t<meta property=\"og:site_name\" content=\"Veeva Systems Korea Site\" \/>\n\t\t<meta property=\"og:type\" content=\"article\" \/>\n\t\t<meta property=\"og:title\" content=\"Keryx Biopharmaceuticals Turns to Veeva Commercial Cloud to Support First FDA-Approved Product Launch | Veeva Systems Korea Site\" \/>\n\t\t<meta property=\"og:description\" content=\"Keryx turns to Veeva Commercial Cloud to support first FDA-approved product launch.\" \/>\n\t\t<meta property=\"og:url\" content=\"https:\/\/www.veeva.com\/kr\/resources\/keryx-biopharmaceuticals-turns-to-veeva-commercial-cloud-to-support-first-fda-approved-product-launch\/\" \/>\n\t\t<meta property=\"og:image\" content=\"https:\/\/www.veeva.com\/kr\/wp-content\/uploads\/2020\/08\/Generic-Social-Banners_v3_Veeva-Generic.png\" \/>\n\t\t<meta property=\"og:image:secure_url\" content=\"https:\/\/www.veeva.com\/kr\/wp-content\/uploads\/2020\/08\/Generic-Social-Banners_v3_Veeva-Generic.png\" \/>\n\t\t<meta property=\"og:image:width\" content=\"1200\" \/>\n\t\t<meta property=\"og:image:height\" content=\"630\" \/>\n\t\t<meta property=\"article:published_time\" content=\"2022-02-18T04:39:25+00:00\" \/>\n\t\t<meta property=\"article:modified_time\" content=\"2026-03-26T09:27:12+00:00\" \/>\n\t\t<meta name=\"twitter:card\" content=\"summary\" \/>\n\t\t<meta name=\"twitter:title\" content=\"Keryx Biopharmaceuticals Turns to Veeva Commercial Cloud to Support First FDA-Approved Product Launch | Veeva Systems Korea Site\" \/>\n\t\t<meta name=\"twitter:description\" content=\"Keryx turns to Veeva Commercial Cloud to support first FDA-approved product launch.\" \/>\n\t\t<meta name=\"twitter:image\" content=\"https:\/\/www.veeva.com\/kr\/wp-content\/uploads\/2020\/08\/Generic-Social-Banners_v3_Veeva-Generic.png\" \/>\n\t\t<script type=\"application\/ld+json\" class=\"aioseo-schema\">\n\t\t\t{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.veeva.com\\\/kr\\\/resources\\\/keryx-biopharmaceuticals-turns-to-veeva-commercial-cloud-to-support-first-fda-approved-product-launch\\\/#breadcrumblist\",\"itemListElement\":[{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/www.veeva.com\\\/kr#listItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.veeva.com\\\/kr\",\"nextItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/www.veeva.com\\\/kr\\\/resources\\\/#listItem\",\"name\":\"Resources\"}},{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/www.veeva.com\\\/kr\\\/resources\\\/#listItem\",\"position\":2,\"name\":\"Resources\",\"item\":\"https:\\\/\\\/www.veeva.com\\\/kr\\\/resources\\\/\",\"nextItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/www.veeva.com\\\/kr\\\/resource-area\\\/commercial\\\/#listItem\",\"name\":\"Commercial\"},\"previousItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/www.veeva.com\\\/kr#listItem\",\"name\":\"Home\"}},{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/www.veeva.com\\\/kr\\\/resource-area\\\/commercial\\\/#listItem\",\"position\":3,\"name\":\"Commercial\",\"item\":\"https:\\\/\\\/www.veeva.com\\\/kr\\\/resource-area\\\/commercial\\\/\",\"nextItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/www.veeva.com\\\/kr\\\/resources\\\/keryx-biopharmaceuticals-turns-to-veeva-commercial-cloud-to-support-first-fda-approved-product-launch\\\/#listItem\",\"name\":\"Keryx Biopharmaceuticals Turns to Veeva Commercial Cloud to Support First FDA-Approved Product Launch\"},\"previousItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/www.veeva.com\\\/kr\\\/resources\\\/#listItem\",\"name\":\"Resources\"}},{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/www.veeva.com\\\/kr\\\/resources\\\/keryx-biopharmaceuticals-turns-to-veeva-commercial-cloud-to-support-first-fda-approved-product-launch\\\/#listItem\",\"position\":4,\"name\":\"Keryx Biopharmaceuticals Turns to Veeva Commercial Cloud to Support First FDA-Approved Product Launch\",\"previousItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/www.veeva.com\\\/kr\\\/resource-area\\\/commercial\\\/#listItem\",\"name\":\"Commercial\"}}]},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/www.veeva.com\\\/kr\\\/#organization\",\"name\":\"Veeva Systems Korea Site\",\"url\":\"https:\\\/\\\/www.veeva.com\\\/kr\\\/\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.veeva.com\\\/kr\\\/resources\\\/keryx-biopharmaceuticals-turns-to-veeva-commercial-cloud-to-support-first-fda-approved-product-launch\\\/#webpage\",\"url\":\"https:\\\/\\\/www.veeva.com\\\/kr\\\/resources\\\/keryx-biopharmaceuticals-turns-to-veeva-commercial-cloud-to-support-first-fda-approved-product-launch\\\/\",\"name\":\"Keryx Biopharmaceuticals Turns to Veeva Commercial Cloud to Support First FDA-Approved Product Launch | Veeva Systems Korea Site\",\"description\":\"Keryx turns to Veeva Commercial Cloud to support first FDA-approved product launch.\",\"inLanguage\":\"ko-KR\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.veeva.com\\\/kr\\\/#website\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.veeva.com\\\/kr\\\/resources\\\/keryx-biopharmaceuticals-turns-to-veeva-commercial-cloud-to-support-first-fda-approved-product-launch\\\/#breadcrumblist\"},\"image\":{\"@type\":\"ImageObject\",\"url\":\"https:\\\/\\\/www.veeva.com\\\/kr\\\/wp-content\\\/uploads\\\/2022\\\/02\\\/Keryx-Biopharmaceuticals-Turns-to-Veeva-Commercial-Cloud.jpg\",\"@id\":\"https:\\\/\\\/www.veeva.com\\\/kr\\\/resources\\\/keryx-biopharmaceuticals-turns-to-veeva-commercial-cloud-to-support-first-fda-approved-product-launch\\\/#mainImage\",\"width\":340,\"height\":240},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.veeva.com\\\/kr\\\/resources\\\/keryx-biopharmaceuticals-turns-to-veeva-commercial-cloud-to-support-first-fda-approved-product-launch\\\/#mainImage\"},\"datePublished\":\"2022-02-17T23:39:25-05:00\",\"dateModified\":\"2026-03-26T05:27:12-04:00\"},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.veeva.com\\\/kr\\\/#website\",\"url\":\"https:\\\/\\\/www.veeva.com\\\/kr\\\/\",\"name\":\"Veeva Systems Korea Site\",\"inLanguage\":\"ko-KR\",\"publisher\":{\"@id\":\"https:\\\/\\\/www.veeva.com\\\/kr\\\/#organization\"}}]}\n\t\t<\/script>\n\t\t<!-- All in One SEO Pro -->\r\n\t\t<title>Keryx Biopharmaceuticals Turns to Veeva Commercial Cloud to Support First FDA-Approved Product Launch | Veeva Systems Korea Site<\/title>\n\n","aioseo_head_json":{"title":"Keryx Biopharmaceuticals Turns to Veeva Commercial Cloud to Support First FDA-Approved Product Launch | Veeva Systems Korea Site","description":"Keryx turns to Veeva Commercial Cloud to support first FDA-approved product launch.","canonical_url":"https:\/\/www.veeva.com\/kr\/resources\/keryx-biopharmaceuticals-turns-to-veeva-commercial-cloud-to-support-first-fda-approved-product-launch\/","robots":"max-snippet:-1, max-image-preview:large, max-video-preview:-1","keywords":"","webmasterTools":{"miscellaneous":""},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"BreadcrumbList","@id":"https:\/\/www.veeva.com\/kr\/resources\/keryx-biopharmaceuticals-turns-to-veeva-commercial-cloud-to-support-first-fda-approved-product-launch\/#breadcrumblist","itemListElement":[{"@type":"ListItem","@id":"https:\/\/www.veeva.com\/kr#listItem","position":1,"name":"Home","item":"https:\/\/www.veeva.com\/kr","nextItem":{"@type":"ListItem","@id":"https:\/\/www.veeva.com\/kr\/resources\/#listItem","name":"Resources"}},{"@type":"ListItem","@id":"https:\/\/www.veeva.com\/kr\/resources\/#listItem","position":2,"name":"Resources","item":"https:\/\/www.veeva.com\/kr\/resources\/","nextItem":{"@type":"ListItem","@id":"https:\/\/www.veeva.com\/kr\/resource-area\/commercial\/#listItem","name":"Commercial"},"previousItem":{"@type":"ListItem","@id":"https:\/\/www.veeva.com\/kr#listItem","name":"Home"}},{"@type":"ListItem","@id":"https:\/\/www.veeva.com\/kr\/resource-area\/commercial\/#listItem","position":3,"name":"Commercial","item":"https:\/\/www.veeva.com\/kr\/resource-area\/commercial\/","nextItem":{"@type":"ListItem","@id":"https:\/\/www.veeva.com\/kr\/resources\/keryx-biopharmaceuticals-turns-to-veeva-commercial-cloud-to-support-first-fda-approved-product-launch\/#listItem","name":"Keryx Biopharmaceuticals Turns to Veeva Commercial Cloud to Support First FDA-Approved Product Launch"},"previousItem":{"@type":"ListItem","@id":"https:\/\/www.veeva.com\/kr\/resources\/#listItem","name":"Resources"}},{"@type":"ListItem","@id":"https:\/\/www.veeva.com\/kr\/resources\/keryx-biopharmaceuticals-turns-to-veeva-commercial-cloud-to-support-first-fda-approved-product-launch\/#listItem","position":4,"name":"Keryx Biopharmaceuticals Turns to Veeva Commercial Cloud to Support First FDA-Approved Product Launch","previousItem":{"@type":"ListItem","@id":"https:\/\/www.veeva.com\/kr\/resource-area\/commercial\/#listItem","name":"Commercial"}}]},{"@type":"Organization","@id":"https:\/\/www.veeva.com\/kr\/#organization","name":"Veeva Systems Korea Site","url":"https:\/\/www.veeva.com\/kr\/"},{"@type":"WebPage","@id":"https:\/\/www.veeva.com\/kr\/resources\/keryx-biopharmaceuticals-turns-to-veeva-commercial-cloud-to-support-first-fda-approved-product-launch\/#webpage","url":"https:\/\/www.veeva.com\/kr\/resources\/keryx-biopharmaceuticals-turns-to-veeva-commercial-cloud-to-support-first-fda-approved-product-launch\/","name":"Keryx Biopharmaceuticals Turns to Veeva Commercial Cloud to Support First FDA-Approved Product Launch | Veeva Systems Korea Site","description":"Keryx turns to Veeva Commercial Cloud to support first FDA-approved product launch.","inLanguage":"ko-KR","isPartOf":{"@id":"https:\/\/www.veeva.com\/kr\/#website"},"breadcrumb":{"@id":"https:\/\/www.veeva.com\/kr\/resources\/keryx-biopharmaceuticals-turns-to-veeva-commercial-cloud-to-support-first-fda-approved-product-launch\/#breadcrumblist"},"image":{"@type":"ImageObject","url":"https:\/\/www.veeva.com\/kr\/wp-content\/uploads\/2022\/02\/Keryx-Biopharmaceuticals-Turns-to-Veeva-Commercial-Cloud.jpg","@id":"https:\/\/www.veeva.com\/kr\/resources\/keryx-biopharmaceuticals-turns-to-veeva-commercial-cloud-to-support-first-fda-approved-product-launch\/#mainImage","width":340,"height":240},"primaryImageOfPage":{"@id":"https:\/\/www.veeva.com\/kr\/resources\/keryx-biopharmaceuticals-turns-to-veeva-commercial-cloud-to-support-first-fda-approved-product-launch\/#mainImage"},"datePublished":"2022-02-17T23:39:25-05:00","dateModified":"2026-03-26T05:27:12-04:00"},{"@type":"WebSite","@id":"https:\/\/www.veeva.com\/kr\/#website","url":"https:\/\/www.veeva.com\/kr\/","name":"Veeva Systems Korea Site","inLanguage":"ko-KR","publisher":{"@id":"https:\/\/www.veeva.com\/kr\/#organization"}}]},"og:locale":"ko_KR","og:site_name":"Veeva Systems Korea Site","og:type":"article","og:title":"Keryx Biopharmaceuticals Turns to Veeva Commercial Cloud to Support First FDA-Approved Product Launch | Veeva Systems Korea Site","og:description":"Keryx turns to Veeva Commercial Cloud to support first FDA-approved product launch.","og:url":"https:\/\/www.veeva.com\/kr\/resources\/keryx-biopharmaceuticals-turns-to-veeva-commercial-cloud-to-support-first-fda-approved-product-launch\/","og:image":"https:\/\/www.veeva.com\/kr\/wp-content\/uploads\/2020\/08\/Generic-Social-Banners_v3_Veeva-Generic.png","og:image:secure_url":"https:\/\/www.veeva.com\/kr\/wp-content\/uploads\/2020\/08\/Generic-Social-Banners_v3_Veeva-Generic.png","og:image:width":1200,"og:image:height":630,"article:published_time":"2022-02-18T04:39:25+00:00","article:modified_time":"2026-03-26T09:27:12+00:00","twitter:card":"summary","twitter:title":"Keryx Biopharmaceuticals Turns to Veeva Commercial Cloud to Support First FDA-Approved Product Launch | Veeva Systems Korea Site","twitter:description":"Keryx turns to Veeva Commercial Cloud to support first FDA-approved product launch.","twitter:image":"https:\/\/www.veeva.com\/kr\/wp-content\/uploads\/2020\/08\/Generic-Social-Banners_v3_Veeva-Generic.png"},"aioseo_meta_data":{"post_id":"29973","title":null,"description":null,"keywords":null,"keyphrases":{"focus":{"keyphrase":"","score":0,"analysis":{"keyphraseInTitle":{"score":0,"maxScore":9,"error":1}}},"additional":[]},"primary_term":null,"canonical_url":null,"og_title":null,"og_description":null,"og_object_type":"default","og_image_type":"default","og_image_url":null,"og_image_width":null,"og_image_height":null,"og_image_custom_url":null,"og_image_custom_fields":null,"og_video":"","og_custom_url":null,"og_article_section":null,"og_article_tags":null,"twitter_use_og":false,"twitter_card":"default","twitter_image_type":"default","twitter_image_url":null,"twitter_image_custom_url":null,"twitter_image_custom_fields":null,"twitter_title":null,"twitter_description":null,"schema":{"blockGraphs":[],"customGraphs":[],"default":{"data":{"Article":[],"Course":[],"Dataset":[],"FAQPage":[],"Movie":[],"Person":[],"Product":[],"ProductReview":[],"Car":[],"Recipe":[],"Service":[],"SoftwareApplication":[],"WebPage":{"id":"aioseo-web-page-63bdb00e3b9db","slug":"web-page","graphName":"WebPage","label":"Web Page","properties":{"type":"WebPage","name":"","description":""}}},"graphName":"WebPage","isEnabled":true},"graphs":[]},"schema_type":"default","schema_type_options":"{\"article\":{\"articleType\":\"BlogPosting\"},\"course\":{\"name\":\"\",\"description\":\"\",\"provider\":\"\"},\"faq\":{\"pages\":[]},\"product\":{\"reviews\":[]},\"recipe\":{\"ingredients\":[],\"instructions\":[],\"keywords\":[]},\"software\":{\"reviews\":[],\"operatingSystems\":[]},\"webPage\":{\"webPageType\":\"WebPage\"}}","pillar_content":false,"robots_default":true,"robots_noindex":false,"robots_noarchive":false,"robots_nosnippet":false,"robots_nofollow":false,"robots_noimageindex":false,"robots_noodp":false,"robots_notranslate":false,"robots_max_snippet":"-1","robots_max_videopreview":"-1","robots_max_imagepreview":"large","priority":null,"frequency":"default","local_seo":null,"limit_modified_date":false,"open_ai":"{\"title\":{\"suggestions\":[],\"usage\":0},\"description\":{\"suggestions\":[],\"usage\":0}}","created":"2022-02-18 04:37:04","updated":"2026-08-24 16:41:13","focus_keyword":null,"additional_keywords":null,"truseo_locale":null,"ai":null,"breadcrumb_settings":null,"seo_analyzer_scan_date":"2026-08-21 21:38:10"},"aioseo_breadcrumb":"<div class=\"aioseo-breadcrumbs\"><span class=\"aioseo-breadcrumb\">\n\t<a href=\"https:\/\/www.veeva.com\/kr\" title=\"Home\">Home<\/a>\n<\/span><span class=\"aioseo-breadcrumb-separator\">&raquo;<\/span><span class=\"aioseo-breadcrumb\">\n\t<a href=\"https:\/\/www.veeva.com\/kr\/resources\/\" title=\"Resources\">Resources<\/a>\n<\/span><span class=\"aioseo-breadcrumb-separator\">&raquo;<\/span><span class=\"aioseo-breadcrumb\">\n\t<a href=\"https:\/\/www.veeva.com\/kr\/resource-area\/commercial\/\" title=\"Commercial\">Commercial<\/a>\n<\/span><span class=\"aioseo-breadcrumb-separator\">&raquo;<\/span><span class=\"aioseo-breadcrumb\">\n\tKeryx Biopharmaceuticals Turns to Veeva Commercial Cloud to Support First FDA-Approved Product Launch\n<\/span><\/div>","aioseo_breadcrumb_json":[{"label":"Home","link":"https:\/\/www.veeva.com\/kr"},{"label":"Resources","link":"https:\/\/www.veeva.com\/kr\/resources\/"},{"label":"Commercial","link":"https:\/\/www.veeva.com\/kr\/resource-area\/commercial\/"},{"label":"Keryx Biopharmaceuticals Turns to Veeva Commercial Cloud to Support First FDA-Approved Product Launch","link":"https:\/\/www.veeva.com\/kr\/resources\/keryx-biopharmaceuticals-turns-to-veeva-commercial-cloud-to-support-first-fda-approved-product-launch\/"}],"_links":{"self":[{"href":"https:\/\/www.veeva.com\/kr\/wp-json\/wp\/v2\/resources\/29973","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.veeva.com\/kr\/wp-json\/wp\/v2\/resources"}],"about":[{"href":"https:\/\/www.veeva.com\/kr\/wp-json\/wp\/v2\/types\/resources"}],"version-history":[{"count":1,"href":"https:\/\/www.veeva.com\/kr\/wp-json\/wp\/v2\/resources\/29973\/revisions"}],"predecessor-version":[{"id":32826,"href":"https:\/\/www.veeva.com\/kr\/wp-json\/wp\/v2\/resources\/29973\/revisions\/32826"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.veeva.com\/kr\/wp-json\/wp\/v2\/media\/30357"}],"wp:attachment":[{"href":"https:\/\/www.veeva.com\/kr\/wp-json\/wp\/v2\/media?parent=29973"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}